Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 414 followers
Latest posts
Last updated about 10 hours ago
GSK prepares frontline FDA bid for Jideytro, its first lung cancer drug
about 10 hours ago
GSK is advancing its inaugural lung cancer asset, Jideytro, toward a landmark...
Increased deaths shadow AstraZeneca, Daiichi’s Enhertu first-line lung cancer data
about 10 hours ago
A preliminary 15% higher death risk in a phase 3 trial threatens...
Merck, Gilead’s failed Trodelvy lung cancer trial shows better China results
1 day ago
Newly revealed global phase 3 data from Merck and Gilead’s failed Trodelvy...
Akeso, Summit’s ivonescimab tops Keytruda in lung cancer survival, with strong data in PD-L1-high patients
1 day ago
Akeso and Summit’s ivonescimab reduced the risk of death by 27% compared...
AstraZeneca’s Etcamah flunks first-line breast cancer trial, adding to oral SERDs’ failure record
1 day ago
Etcamah now joins Roche’s rival oral SERD, giredestrant, in missing the mark...
After FDA nod for novel Cabometyx formulation, analysts predict limited threat to Exelixis
3 days ago
Following formal sign-off from the FDA, Handa Pharmaceuticals’ branded drug reformulation strategy...
How is API Manufacturing Changing?
3 days ago
WuXi AppTec’s Ke Chen discusses trends reshaping API manufacturing – while diligence...
Fierce Pharma Asia—Takeda’s R&D leadership change; Daiichi’s $1.3B court win; New Samsung Bio contract
3 days ago
Takeda's long-time R&D chief Andy Plump will retire. Daiichi Sankyo beat back...
CDMO Argonaut sheds life sciences, diagnostics division for undisclosed sum
3 days ago
Argonaut Manufacturing Services, a CDMO specializing in aseptic fill-finish for injectable biologics...
In first interview as FDA oncology chief, Angelo de Claro vows to ‘continue the innovation’ behind OCE legacy
3 days ago
In his first interview after taking the reins of the FDA’s Oncology...
Biopharma’s next data advantage may start with genetics
4 days ago
Real-world data has become table stakes. The next challenge is connecting it...
Swiss CDMOS making moves: Lonza bets on new US facility, CordenPharma scales injectables with €80M
4 days ago
Lonza's plans for a new spray-drying facility in Bend, Oregon, affirm the...